Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5

被引:15
|
作者
Boensch, Claudia [1 ]
Munteanu, Mihaela [1 ]
Rossitto-Borlat, Irene [1 ]
Fuerstenberg, Alexandre [2 ]
Hartley, Oliver [1 ]
机构
[1] Univ Geneva, Dept Pathol & Immunol, Fac Med, Geneva, Switzerland
[2] Univ Geneva, Fac Med, Dept Human Prot Sci, Geneva, Switzerland
来源
PLOS ONE | 2015年 / 10卷 / 04期
基金
瑞士国家科学基金会;
关键词
PROTEIN-COUPLED RECEPTORS; HIGHLY POTENT; ENTRY INHIBITORS; TRAFFICKING; ARRESTIN; RANTES; INTERNALIZATION; IDENTIFICATION; STIMULATION; INFECTIVITY;
D O I
10.1371/journal.pone.0125396
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
G protein-coupled receptors (GPCRs) are desensitized and internalized following activation. They are then subjected to post-endocytic sorting (degradation, slow recycling or fast recycling). The majority of research on post-endocytic sorting has focused on the role of sequence-encoded address structures on receptors. This study focuses on trafficking of CCR5, a GPCR chemokine receptor and the principal entry coreceptor for HIV. Using Chinese Hamster Ovary cells stably expressing CCR5 we show that two different anti-HIV chemokine analogs, PSC-RANTES and 5P14-RANTES, direct receptor trafficking into two distinct subcellular compartments: the trans-Golgi network and the endosome recycling compartment, respectively. Our results indicate that a likely mechanism for ligand-directed sorting of CCR5 involves capacity of the chemokine analogs to elicit the formation of durable complexes of CCR5 and arrestin2 (beta-arrestin-1), with PSC-RANTES eliciting durable association in contrast to 5P14-RANTES, which elicits only transient association.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] CCR5 antagonists with anti-HIV activity: Is inhibition on the cell surface sufficient?
    Springer, M
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135
  • [22] The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection
    Lehner, T
    TRENDS IN IMMUNOLOGY, 2002, 23 (07) : 347 - 351
  • [23] GW-873140 - Anti-HIV therapy HIV entry inhibitor CCR5 antagonist
    McIntyre, JA
    DRUGS OF THE FUTURE, 2004, 29 (07) : 677 - 679
  • [24] Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugs
    Nakata, Hirotorno
    Steinberg, Seth M.
    Koh, Yasuhiro
    Maeda, Kenji
    Takaoka, Yoshikazu
    Tarnarnura, Hirokazu
    Fujii, Nobutaka
    Mitsuya, Hiroaki
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) : 2111 - 2119
  • [25] Analyses of Anti-HIV Type 1 Activity of a Small CCR5 Peptide Antagonist
    Wang, Fang Yu
    He, Shu Ya
    Zhang, Zhi Jian
    He, Li Fang
    Chen, Xiao Wei
    Teng, Tao
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : 1111 - 1115
  • [26] Combining a conditional suicide gene with CCR5 knockout for anti-HIV gene therapy
    Yeh, R.
    Mehmetoglu-Gurbuz, T.
    Joshi, A.
    Garg, H.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 4 - 5
  • [27] CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activity
    Lynch, CL
    Hale, JJ
    Budhu, RJ
    Gentry, AL
    Finke, PE
    Caldwell, CG
    Mills, SG
    MacCoss, M
    Shen, DM
    Chapman, KT
    Malkowitz, L
    Springer, MS
    Gould, SL
    DeMartino, JA
    Siciliano, SJ
    Cascieri, MA
    Carella, A
    Carver, G
    Karen, H
    Schleif, WA
    Danzeisen, R
    Hazuda, D
    Kessler, J
    Lineberger, J
    Miller, M
    Emini, E
    ORGANIC LETTERS, 2003, 5 (14) : 2473 - 2475
  • [28] MegaTAL Disruption of CCR5 To Protect Anti-HIV CAR plus Lymphocytes from HIV Infection
    Wagner, Thor A.
    Hale, Malika
    Romano, Guillermo
    Kahn, Iram
    Sahni, Jaya
    Scharenberg, Andy
    Rawlings, David J.
    MOLECULAR THERAPY, 2015, 23 : S179 - S180
  • [29] CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box
    Ellwanger, Joel Henrique
    Kaminski, Valeria de Lima
    Rodrigues, Andressa Goncalves
    Kulmann-Leal, Bruna
    Chies, Jose Artur Bogo
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2020, 47 (03) : 261 - 285
  • [30] Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii
    Yarovinsky, F
    Andersen, JF
    King, LR
    Caspar, P
    Aliberti, J
    Golding, H
    Sher, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (51) : 53635 - 53642